Postdoctoral Position for Research on Glioma Heterogeneity
June 6, 2018
La Jolla, California
Full Time - Entry Level
Basic Science, Neuro-Oncology
The Ludwig Institute for Cancer Research is an international non-profit research organization dedicated to improving the understanding and control of cancer. Please visit our website for more information: http://www.licr.org
Postdoctoral Training Opportunity Research on Glioma Heterogeneity
Position Summary The laboratory of Tumor Biology, led by Dr. Frank Furnari, has an opening for a Postdoctoral trainee to study glioma heterogeneity promoted by tumor cell and microenvironment interactions (Zanca et al, Genes and Development, 2017). The ideal candidate should have the following skill sets and qualifications:
has worked with glioma neuropsheres and PDX models
mouse work including orthotopic engraftments
technical skills including molecular and cellular biology, protein biochemistry, and CRISPR/Cas9 engineering.
knowledge of epigenetic techniques and associated bioinformatics would definitely be a plus.
Candidates for this position must have a Ph.D., first author publications, good writing skills, ability to work well with others and possess a strong work ethic and drive.
Application Process Interested applicants should submit a copy of their CV, the contact information (email address and phone number) of three references, and a brief statement of research skills and interest to Dr. Frank Furnari: FFurnari@UCSD.edu
The Ludwig Institute is an Equal Opportunity Employer
About Ludwig Institute-UCSD
The Ludwig Institute for Cancer Research is an international not-for-profit organization that originates and conducts long-range research programs directed to the ultimate goal of eradicating cancer. Over 750 scientists, clinicians, and support staff in 14 countries focus on multiple aspects of basic and clinical cancer research, including cancer genetics and genomics, tumor immunology, and cell growth and differentiation.
The majority of the researchers work at the Institute's 9 Branches, located in 7 different countries. Each Branch functions in close association with a local university and a non-for-profit hospital. A number of affiliated individual investigators and laboratories complement the Institute's Branch network and extend its global reach.
Convinced that the discovery process has not run its course until promising laboratory findings have been tested in the clinic, the Institute is committed to translating its basic research discoveries into therapeutic practices. Having established GMP reagent production and regulatory and monitoring capabilities in-house, the Institute is an active sponsor of its own clinical trials.